PIDACMERAN
UNII 6FH8H9CL41

Substance Identification & Data

This profile provides standardized clinical and technical data for Pidacmeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6FH8H9CL41.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2417904-10-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6FH8H9CL41

CAS Registry Number

2417904-10-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PIDACMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173056

National Cancer Institute reference terminology for clinical and research data.

INN ID

11891

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pidacmeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PIDACMERAN

Common Names & Synonyms

PIDACMERAN [INN]

PIDACMERAN [WHO-DD]

RNA (RECOMBINANT 5'-(1,2-(M7GM-(5'->5')-P-(P(R))-SP-P-G))-CAPPED VENEZUELAN EQUINE ENCEPHALITIS VIRUS PROTEINS NSP1-, NSP2-, NSP3-AND NSP4 (RNA-DEPENDENT RNA POLYMERASE)-SPECIFYING PLUS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SECRETORY SIGNAL PEPTIDE-CONTAINING SPIKE GLYCOPROTEIN S1S2-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER BNT162C2), INNER SALT

Technical Codes

BNT162C2

BNT-162C2

External Clinical & Regulatory Resources

Previous UNII6FH89HG6AW

Next UNII6FHZ595FNM